Pfizer Venture Investments

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Pfizer Venture Investments — overview

About

Pfizer Venture Investments (PVI) is the US-based venture capital arm of Pfizer. The firm invests in emerging companies developing transformative medicines and technologies in areas of current or future strategic interest to Pfizer globally, but primarily in the US. PVI focuses on direct investments in private companies across all stages, with a particular emphasis on early-stage opportunities.

Pfizer Venture Investments - known decision makers (14)

Position	Location	Asset Class
Chairman & Chief Executive Officer	New York, US	PE
Chief Financial Officer & Executive Vice President	New York, US	PE
Partner & Executive Director, Worldwide Business Development	New York, US	PE
Executive Director	New York, US	PE
Executive Director, WWBD / Partner	New York, US	PE

Showing 5 of 14 known decision makers Pfizer Venture Investments

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo